No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
HUN240517C24000
- 0.85
- -0.60-41.38%
15min DelayClose May 10 16:00 ET
0.85High0.85Low
0.85Open1.45Pre Close1 Volume166 Open Interest24.00Strike Price85.00Turnover0.00%IV-0.42%PremiumMay 17, 2024Expiry Date0.83Intrinsic Value100Multiplier6DDays to Expiry0.02Time Value100Contract SizeAmericanOptions Type--Delta--Gamma34.25Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
Express News | NYSE Order Imbalance 124137.0 Shares on Buy Side
Huntsman To Go Ex-Dividend On June 14th, 2024 With 0.25 USD Dividend Per Share
May 10th - $Huntsman(HUN.US)$ is trading ex-dividend on June 14th, 2024. Shareholders of record on June 14th, 2024 will receive 0.25 USD dividend per share on June 28th, 2024. The ex-dividend date
Press Release: Huntsman Announces Second Quarter 2024 Common Dividend
Huntsman Announces Second Quarter 2024 Common Dividend PR Newswire THE WOODLANDS, Texas, May 9, 2024 THE WOODLANDS, Texas, May 9, 2024 /PRNewswire/ -- Huntsman Corporation (NYSE: HUN) announced tod
Analysts Offer Insights on Materials Companies: Orica Limited (OtherOCLDF) and Huntsman (HUN)
What Analysts Are Saying About Huntsman Stock
Throughout the last three months, 4 analysts have evaluated Huntsman (NYSE:HUN), offering a diverse set of opinions from bullish to bearish.The table below offers a condensed view of their recent rati
Huntsman Is Maintained at Sector Perform by RBC Capital
Huntsman Is Maintained at Sector Perform by RBC Capital
Comments
Despite low growth, undervalued Huntsman shares might be a good investment. However, the company's financial health is also key to consider. Its future outlook is possibly not fully reflected yet, offering a potentially attractive opportunity.
Should You Investigate Huntsman Corporation (NYSE:HUN) At US$24.82?Huntsman's low P/S ratio is down to limited revenue growth predictions. Failure to increase its revenue might keep its share price low and possibly lower P/S levels.
Huntsman's stagnant business growth, marked by a declining ROCE and stable capital employed, dampens its investment appeal despite a robust 43% stock return over five years.
Gapping up
In reaction to earnings/guidance:
• $Bowlero(BOWL.US$ +3.4%
Other news:
• $Intellia Therapeutics(NTLA.US$ +10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002)
• $Gogo Inc(GOGO.US$ +5% (Repurchases 1.5 million shares of common stock from BlackRock)
• $ADC Therapeutics(ADCT.US$ +2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...
In reaction to earnings/guidance:
• $Bowlero(BOWL.US$ +3.4%
Other news:
• $Intellia Therapeutics(NTLA.US$ +10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002)
• $Gogo Inc(GOGO.US$ +5% (Repurchases 1.5 million shares of common stock from BlackRock)
• $ADC Therapeutics(ADCT.US$ +2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...
13
Gainers:
• $National Vision(EYE.US$ +13.8% (appointed to join S&P SmallCap 600)
• $Braze(BRZE.US$ +12.2% (In reaction to earnings/guidance)
• $Oracle(ORCL.US$ +11.7% (In reaction to earnings/guidance)
• $TeraWulf(WULF.US$ +7.5% (announced recent financing actions and near-term ramp of digital infrastructure)
• $Continental Resources(CLR.US$ +7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share)
•...
• $National Vision(EYE.US$ +13.8% (appointed to join S&P SmallCap 600)
• $Braze(BRZE.US$ +12.2% (In reaction to earnings/guidance)
• $Oracle(ORCL.US$ +11.7% (In reaction to earnings/guidance)
• $TeraWulf(WULF.US$ +7.5% (announced recent financing actions and near-term ramp of digital infrastructure)
• $Continental Resources(CLR.US$ +7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share)
•...
8
4
Read more